// App-Quantinova.ai

1726 : Clinical efficacy and safety profile of allergen‐specific immunotherapy using microcrystalline tyrosine (MCT)‐adsorbed allergoids – A meta‐analysis

Researchers

Presenter

  • Becker S

Principal Investigators

  • Zieglmayer P

  • Canto G

  • Fassio F

  • Yong P

  • Acikel C

  • Raskopf E

  • Steveling E

  • Allekotte S

  • Msges R

Medical Centers

  • Department of Otorhinolaryngology, Head and Neck Surgery, University Medicine Gottingen, Gottingen, Germany

  • Vienna Challenge Chamber, Vienna, Austria

  • Hospital Infanta Sofia, Madrid, Spain

  • Allergy and Clinical Immunology Unit, Azienda Usl Toscana Centro, Ospedale San Giovanni di Dio, Firenze, Italy

  • Frimley Park Hospital, Frimley, UK and Royal Surrey County Hospital, Guildford, United Kingdom

  • ClinCompetence Cologne GmbH, Cologne, Germany

  • Dermatology Department, Division of Allergy, University Hospital Basel, Basel, Switzerland

  • Institute of Medical Statistics and Computational Biology, University Hospital Cologne, Cologne, Germany

Locations

  • Germany

  • Austria

  • Spain

  • Italy

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved